Irisin and Visfatin Predicts Severity of Diabetic Nephropathy
Although the roles of irisin and visfatin have been well established in diabetes mellitus, there are limited studies about their association in diabetic nephropathy. The present study was designed to assess the levels of irisin and visfatin and their association with the severity of diabetic nephropathy. 43 diabetic nephropathy cases and 43 diabetic subjects without nephropathy were enrolled in the study. Serum levels of irisin and visfatin were compared in both the groups. Irisin and visfatin were significantly increased in diabetic nephropathy cases when compared with diabetes subjects without nephropathy. eGFR was negatively correlated with visfatin (r = −0.323, p = 0.034), irisin (r = −0.324, p = 0.034), urine albumin (r = −0.443, p = 0.003) and albumin creatinine ratio (r = −0.419, p = 0.005) in patients with diabetic nephropathy. Visfatin was significantly elevated in stage IV nephropathy compared with stage III nephropathy. We conclude that irisin and visfatin are elevated in diabetic nephropathy and can be an index of its severity.
KeywordsDiabetes mellitus Nephropathy Irisin Visfatin Adiponectin
End stage renal disease
Glomerular filtration rate
Chronic kidney disease
Albumin creatinine ratio
This work was supported by a intramural grant from JIPMER, Puducherry to the corresponding author.
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.